BioWorld

April 30, 2010

View Archived Issues

Well-Timed Wnt Can Speed Bone Healing After Injury

Read More

CEO Stepping Down as Celgene Beats Estimates, Plans Growth

Read More

Corrections & Clarifications

Read More

Affimed Plans to Take Antibodies into Clinic with $26M Series C

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

FDA Clears Provenge; Up Next: Fast Launch, Slow Ramp

Dendreon Corp. made history on Thursday, securing a long sought-after FDA approval for prostate cancer vaccine Provenge (sipuleucel-T). (BioWorld Today) Read More

HCV Specialist Idenix Raising $26.2M in Stock Offering

Read More